Moderate alcohol consumption also reduces mortality in patients with documented CVD.
Light to moderate alcohol consumption (5 to 25 g/day) was associated with a lower incidence of CVD events and all-cause mortality in a recent meta-analysis of 8 prospective studies including 16,351 subjects with history of CVD. J-shaped pooled curves were observed with both CVD and all-cause mortality. [9] In patients with clinically manifest vascular disease or diabetes (n = 5447) from the Second Manifestations of Arterial Disease (SMART) study, moderate alcohol consumption (1-2 drinks/day) was not only associated with a reduced risk of vascular and all-cause death, but also with reduced risks of non-fatal events from CHD, stroke and amputations. [24] In the Prospective Epidemiological Study of Myocardial Infarction (PRIME), in Northern Ireland and France, regular and moderate alcohol intake was associated with a low risk of CHD, whereas the binge drinking pattern conferred a higher risk. [25] Only wine drinking was associated with a lower risk of hard coronary events.
[25] Moderate alcohol intake was inversely associated with CHD in hypertensive men in the Physicians' Health Study, and Health Professionals Follow-Up Study, after 26-and 16-year follow-ups, respectively. [26, 27] Moderate alcohol consumption in the year prior to acute MI was associated with reduced total and CV mortality following infarction, irrespective of gender and beverage type, [28] and a significant reduction in cardiovascular complications in survivors of acute MI. [29] In the Stockholm Heart Epidemiology Program (SHEEP) study, moderate alcohol drinking was beneficial following acute MI, after a median follow up of 8 years. [31] Persistent moderate alcohol drinking following an acute MI was associated with a trend toward less angina, fewer re-hospitalizations, lower 3-year mortality, and better disease-specific quality of life, and mental health than quitters. [32] In the Post-CABG trial, inverse trends were observed between moderate drinking and morbidity as well as graft disease progression. [33] 
Epidemiological Studies Showing Neutral Results of Alcohol on the Heart
While a great many studies have shown favorable effects on CHD and all-cause mortality with light to moderate alcohol intake (Table 1) , some studies have shown a neutral effect, and heavy alcohol consumption was shown to be detrimental. In the Framingham Study, cumulative incidence of alcohol use disorders did not show a decrease despite a decrease in average alcohol intake and more wine consumption after more than 50 years of followup.
[34] Contrary to the cardioprotective effect of moderate regular alcohol consumption, heavy, episodic drinking was related to higher risk of CHD, [35] and indeed in a prospective study of patients with MI, although moderate alcohol intake was associated with lower mortality, binge drinking, even among light drinkers, was associated with 2-fold higher mortality.
[36] A meta-analysis of 14 studies showed the cardioprotective effect of moderate alcohol consumption disappears when, on average, light to moderate drinking was mixed with irregular heavy drinking (>60 g of pure alcohol or > or =5 drinks per occasion at least monthly).
[37] Former drinkers compared to long-term abstainers had significantly increased risk for CHD mortality, in a recent metaanalysis.
[38] In a meta-analysis of six studies, a J-shaped curve, with nadir of approximately 28 grams of alcohol (2 drinks) per week, was observed including drinkers who consumed alcohol for 2 days a week or less. Conversely, in people who consumed alcohol for more than 2 days a week, a significant protective effect was seen even when drinking high amounts of alcohol.
[39] In a meta-analysis of 28 cohort studies, there was a 20% relative risk reduction in CHD for up to 20 g/day of alcohol consumption, and evidence of a protective effect up to 72 g/day, but increased risk above > 89 g/day.
[40]
The beneficial effects of light to moderate alcohol consumption on CHD could not be replicated in some studies, especially in studies of certain ethnic populations. Table 2 lists studies showing no favorable effects of light to moderate alcohol consumption on cardiovascular or all-cause mortality. In the NHANES Epidemiologic Follow-Up Study (NHEFS), no J-shaped beneficial relationship was found between alcohol consumption and mortality in African Americans. Conversely, mortality increased with increasing consumption of more than one drink a day in both genders.
[41] Risk for all-cause mortality was similar for non-drinkers and men drinking up to 14 units per week (1 unit was equivalent to one measure of spirits, half a pint of beer, or one sixth bottle of wine)
in Scottish men followed-up for 21 years, with an unfavorable outcome for drinking over 22 units a week.
[42] In Asian-Indian men, no protective association was found between alcohol intake and prevalence of CHD. In fact, alcohol intake was associated with a higher odds ratio for CHD risk. [43, 44] Moderate-to-heavy alcohol consumption not only showed lack of benefit on CHD mortality in older Chinese men, [45] but also increased the risk of angiographically proven CAD. [46] In the Lipid Research Clinics Prevalence and Follow-up Studies, no difference in mortality rates were found between drinkers and non-drinkers in Russia.
[47] In a cohort of males of high socioeconomic status, moderate alcohol consumption had no net benefit compared with abstinence, and > 3 drinks per day was associated with worse quality of life, and adversely affected mortality after a 29-year follow-up. [48] In a population based prospective study of 7169 men aged 45-64 years followed for a mean of 12.8 years, compared to occasional drinking, regular light alcohol consumption (1-14 units per week) in men with established CHD was not associated with any significant benefit, or all cause mortality. Higher levels of intake (>/= 3 drinks per day)
were associated with increased mortality in men with previous MI. Alcohol consumption was also associated with a lower prevalence of metabolic syndrome in the NHLBI Family Heart Study, irrespective of the type of beverage consumed, [90] and in European population cohorts. 
Alcohol and Lipids

Alcohol and Hypertension
Existing evidence is conflicting regarding the relation between alcohol consumption and systemic hypertension.
In a systematic review and meta-analysis comprising 12 cohort studies from the United States, Japan and Korea, the risk for hypertension increased linearly with alcohol consumption. Among women, a significant protective effect was reported for consumption at or below about 5 g per day. Among men, Asian populations had higher risks than non-Asian populations of hypertension associated with alcohol intake. The mechanisms that lead to alcohol-induced hypertension have not been well defined.
In a study of healthy volunteers, higher blood pressure in drinkers, was not explained by increased activity of the sympatho-adrenal and renal-pressor mechanisms.
[99] Light-tomoderate alcohol intake appeared to have a possible vasculoprotective effect, as measured by pulse wave velocity in subjects with optimal or normal blood pressure, while heavy drinking caused a detrimental effect on the vasculature.[100] Increased aortic pulse wave velocity was closely associated with alcohol consumption in middleaged Japanese men. [101] Polymorphisms of alcohol-metabolizing enzymes (alcohol dehydrogenase (ADH) 2 and aldehyde dehydrogenase (ALDH) 2 may influence alcohol metabolism. One such polymorphism, ADH2(1)/2(1) genotype, was associated with lower levels of systolic blood pressure. [102] Genotypic variations in Catechol-O-methyltransferase (COMT) mRNA and the consequent genetically determined inactivation of catecholamines, may influence alcohol-induced blood pressure elevation. [103] 
Alcohol and Coagulation
Epidemiological studies indicate that consumption of alcohol at the average level of intake in France (20-30 g per day) reduced risk of CHD by at least 40%, despite a high intake of saturated fat. This "French Paradox," may be attributable to regular wine consumption. Alcohol is believed to protect from CHD by preventing atherosclerosis through action on HDL-C, but serum concentrations were no higher in France than in other countries. The effect of wine in lowering the platelet reactivity, as seen in France compared to Scotland, may be one explanation for this protection. [104] In the Framingham Offspring Study, light-to-moderate alcohol consumption was associated with lower levels of coagulatory factors (fibrinogen, plasma viscosity, von
Willebrand factor, and factor VII), but higher intake was associated with impaired fibrinolytic potential, reflected by higher levels of plasminogen activator inhibitor antigen-1 and tissue plasminogen activator antigen. These findings are consistent with the hypothesis that a balance between hemostatic and fibrinolytic activity may contribute to the complex relation of alcohol use with coronary heart disease. [105, 106] A dose-dependent effect of alcohol on decreased platelet aggregation was also seen in the Caerphilly Prospective Heart Disease Study. Moderate alcohol intake was positively associated with plasma level of endogenous t-PA, independent of HDL-C in the Physicians' Health Study. [108] In the NHLBI Family Heart Study, alcohol consumption > 15g/d was associated with increased PAI-1. [109] These findings support the hypothesis that changes in fibrinolytic potential may be an important mechanism whereby moderate alcohol consumption decreases risk of heart disease.
Moderate alcohol consumption also improved endothelial function as evidenced by better flow-mediated dilation (FMD) in the Northern Manhattan Study (NOMAS). [110] 
Alcohol and Inflammation
In view of the robust association between markers of inflammation, especially C-reactive protein (CRP), and risk of CHD, an anti-inflammatory action of alcohol could contribute to the link between moderate consumption and lower cardiovascular mortality.
Multiple studies have demonstrated the beneficial effects of moderate alcohol consumption on various inflammatory markers with significantly decreased levels of plasma CRP, fibrinogen, interleukin-6 (IL-6), interleukin-1alpha, as well as plasma viscosity, WBC count, factor VIIIc, and monocyte and endothelial adhesion molecules. [111] [112] [113] [114] [115] Men who consumed 1-2 drinks/day had 26% lower CRP, and 36% lower IL-6 levels, with a stronger association in women. [116] Lower CRP concentrations were also observed in the Pravastatin Inflammation/CRP Evaluation Study, independent of alcohol-related effects on lipids. [117] These results suggest an additional biological explanation to the epidemiological link between moderate alcohol consumption and decreased cardiovascular events.
Alcohol Preconditioning
Epidemiological data suggest that those who are regularly consuming alcohol prior to an acute MI are more likely to survive, suggesting a preconditioning effect of alcohol. [28, 118] Ischemic preconditioning (IPC) is the most potent form of endogenous myocardial protection against irreversible ischemia-reperfusion injury. In an animal models, longterm alcohol consumption reduced myocardial ischemia-reperfusion injury possibly through repeated myocyte adenosine receptor activation, [119] and sustained translocation of epsilon protein kinase C (εPKC). [120] In situ studies in rabbit showed, ethanol exposure followed by washout or sufficient time to metabolize the alcohol prior to ischemia, induces preconditioning-like myocardial protection. [121] Protection afforded against ischemia and reperfusion injury (I/R) proceeds through an ischemic preconditioning-like mechanism involving the activation of εPKC that is dependent on the time and duration of ethanol treatment. [122, 123] Of note, moderate dose of ethanol when taken acutely, abolished ischemic preconditioning (IPC) occurring during sequential episodes of myocardial ischemia, and is associated with worsening ischemia in a randomized prospective study in humans. [124] 
Wine versus other Alcoholic Beverages
Some but not all, epidemiological studies suggest that wine confers greater protection against CHD than beer or distilled spirits, by virtue of its polyphenol content. [125] In a systematic review and meta-analysis, small doses (1-4 drinks/day) of wine, beer, and spirits were equally beneficial in reducing CHD. [126] Another systematic review that included ecological, case-control, and prospective cohort studies, also showed that all types of alcoholic drinks were linked with lower risk of CHD. [127] However, in a metaanalysis, relative risk of vascular disease associated with wine intake was 0.68 (95% confidence interval, 0.59 to 0.77) in 209 418 persons compared to non-drinkers, with a strong J-shaped relationship between different amounts of wine intake and vascular risk.
A similar but smaller association was also apparent with beer consumption, but no meaningful relationship could be found between different amounts of beer intake and vascular risk. [128] Potential protective mechanisms beyond the effects of ethanol include, greater anti-oxidant effects, [129] [130] [131] decreased erythrocyte superoxide dismutase activity, [132] and in vitro studies showing reduced vascular smooth muscle cells proliferation, [133] vasorelaxation of human coronary arteries, [134] inhibition of endothelin-1 synthesis, [135] and down-regulation of tissue factor (TF) gene transcription. [136] Alcohol and Heart Failure Moderate alcohol consumption was associated with a lower risk of incident heart failure among older adults and in the Physicians' Health Study, independent of a number of confounding factors. Further, it did not appear to be mediated by a reduction in MI risk, after an extended follow-up of 18 years. [137] [138] [139] Light to moderate drinking was associated with a lower risk of HF in hypertensive male physicians. [140] In the Framingham Heart Study, during 26,035 person-years of follow-up in men, and 35,563 person-years of follow-up in women, alcohol consumption was not associated with increased risk for heart failure, even among heavy drinkers (> 15 drinks/wk in men and > 8 drinks/wk in women). To the contrary, moderate alcohol consumption protected against heart failure. [141] In a meta-analysis of 6 studies, infrequent and light-to-moderate drinking was associated with a 10% to 20% lower risk of heart failure. [142] Heavy alcohol drinking was associated with increased risk of non-ischemic cardiomyopathy, and the apparent protection of alcohol against ischemic cardiomyopathy, supported its protective effect against CHD. [143] Alcohol is toxic to striated muscle in a dose-dependent manner, and in patients with alcoholic cardiomyopathy, total lifetime dose of ethanol correlated inversely with the ejection fraction and directly with the left ventricular mass. [144] In the Framingham Offspring Study, alcohol intake was positively and independently associated with left ventricular mass in men but not in women. [145] Subtle signs of cardiac abnormalities such as left ventricular dilation with preserved ejection fraction and impaired left ventricular relaxation may precede severe cardiac dysfunction in chronic asymptomatic alcoholics. [146] Changes in myocardial contractility due to chronic alcohol exposure do not result from altered Ca 2+ handling but from changes at the level of the myofilament that do not involve myosin heavy chain isoform shifts. [147] Transgenic overexpression of insulinlike growth factor 1 attenuated the deleterious effects caused by chronic alcohol intake such as interstitial fibrosis, reduced mitochondrial number, compromised cardiac contractile function and intracellular Ca(2+) handling, decreased superoxide dismutase (SOD) 1 expression, elevated superoxide production, and overt apoptosis, with the exception of cardiac hypertrophy. [148] Abstinence is the most critical step in halting further deterioration of cardiac contractility in alcoholics. In a 4-year prospective cohort study in Spain, left ventricular ejection fraction improved in both abstinent patients and those who controlled their drinking up to
Like the relationship between alcohol and CHD, the relationship between alcohol and CHF is complex. While light to moderate alcohol intake may be protective, heavy consumption increases heart failure risk.
Alcohol and Atrial Fibrillation
Moderate alcohol consumption was not significantly associated with a risk of atrial fibrillation, [150, 151] 
